Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Natalbes - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Natalbes

Approved

STANDARD

Natalbes

Catalent Australia Pty. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 7befb5d5dbcd0994
Company: Catalent Australia Pty. Ltd.
Type: Standard

Approval Details

Approval Id: 7befb5d5dbcd0994
Drug Approval Philippines Name: Natalbes
Product Name: Natalbes
Registration Number: DR-XY9511
Brand Name: Natalbes
Generic Name: Multivitamins + Minerals
Dosage Form: Softgel Capsule
Dosage Strength: N/A
Manufacturer: Catalent Australia Pty. Ltd.
Importer: Meyers Pharmaceuticals (Phils.), Inc.
Distributor: Meyers Pharmaceuticals (Phils.), Inc.
Issuance Date: 28 June 2021
Expiry Date: 04 November 2026
Classification: Over-the-Counter (OTC) Drug

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

7befb5d5dbcd0994

Type

Standard

Back to Philippines FDA Approvals